Bronze
Boditech Med Inc. has beendeveloping products for in-vitro diagnostics and diagnostic reagents for thepast 20 years by pursuing the value of a company called "Respect forLife". In particular, more than25,000 units of ichroma™ readers are installed and operated world wide, andichroma™ CRP (C-Reactive Protein) has secured its largest market share inChina, showing a unique competitiveness.Boditech Med Inc. is leadingthe way in exploring new markets through the automation of on-site diagnosedimmunodiagnostic devices and the development of new high-sensitive diagnosticreagents. We have built up our reputation successfully by carrying out variousnational R&D projects based on solid technology, experience, and human resourcesaccumulated over the years. Inaddition, Boditech Med Inc. is developing a smart production system thatintegrates digital technology and IT technology to flexibly manage theproduction scale. All employees of Boditech Med Inc. are making every effortwith pride that we are the top leader of BT-IT convergence industry in Korea.
AFIAS-6 (AFIAS-automated fluorescent immunoassay system) is an automated fluorescent immunoassay system that uses blood, urine, and other samples to measure quantitatively or semi-quantitatively the concentration of targeted analyte. AFIAS all-in-one cartridges are designed to optimize the structure and operating principle of the reader. Its automated test process enables to carry out multiple simultaneous tests for six different samples. For some specified items such as TSH, CRP, PCT and HbA1c, small volume (10 μL or 50 μL) of whole blood from a finger or heel can be used for quantitative testing using a C-tip (capillary tip).